Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Oraxol |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
Oraxol consists of paclitaxel and HM30181A, a multidrug resistance efflux pump P-glycoprotein (P-gp) inhibitor, which may increase the bioavailability of paclitaxel (PMID: 26112004). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C112000 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Oraxol | Oraxol | 0 | 2 |
| Oraxol + Pembrolizumab | Oraxol Pembrolizumab | 0 | 1 |
| Oraxol + Ramucirumab | Oraxol Ramucirumab | 0 | 1 |